Condition: Malignant Pleural Mesothelioma · Sponsor: Memorial Sloan Kettering Cancer Center
The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure how people respond to standard treatment for malignant pleural mesothelioma (MPM). The researchers will study how E-Nose breathprints change over time as people receive standard treatment for MPM. They will also look at how changes in people's E-Nose breathprints compare to changes in their standard imaging scans and in biomarkers of MPM in their blood.
This description comes directly from the study's public registry record.
Gaetano Rocco, MD · 212-639-3478 · roccog@mskcc.org
David Jones, MD · 212-639-6428
Always discuss trial participation with your own doctor first.
| Memorial Sloan Kettering Basking Ridge (Consent Only) | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth (Consent Only) | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen (Consent Only ) | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only) | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester (Consent Only) | Harrison, New York, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering Nassau (Consent Only) | Uniondale, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06037941